Dr. Kerri Schellenberg MD, FRCPC, CSCN (EMG), MMedEd

Dr. Kerri Schellenberg, MD, FRCPC, MMedEd is a Neuromuscular Neurologist and Associate Professor at the University of Saskatchewan.  She is the Medical Director of the ALS/MND clinic and the Medical Director of the Royal University Hospital EMG lab. She serves as Competency Committee Chair for the neurology program. She has served as co-chair for both the Canadian ALS Research Network (CALS) and Neuromuscular Disease for Canada (NMD4C) Clinical Trial Network. She received the King Charles III coronation medal for contributions to ALS care in the community.

Her research primarily focuses on motor neuron diseases (ALS, SBMA, and SMA), and includes publications in clinical aspects of neuromuscular disease. She has served as local PI for international treatment trials in ALS, led the Canadian guidelines for Spinal Bulbar Muscular Atrophy (SBMA), contributed to Canadian ALS Best Practice Recommendations, local PI for the Canadian Neuromuscular Disease registry, and has ongoing grants and projects with local and national research collaborators to further understand neuromuscular disease. This includes community engagement and study of the highly elevated prevalence of SBMA in people identifying as Indigenous in Saskatchewan.   

She completed her medical studies at the University of Saskatchewan, a neurology residency at the University of Alberta, and a neuromuscular fellowship at Duke University. Dr. Schellenberg was the recipient of the Betty Norman Research Fellowship Award from the ALS Society of Canada to pursue an ALS fellowship at the University of Alberta.  She has a Masters of Medical Education from the University of Dundee.